Abstract
Silica nanoparticles (SNPs) are increasingly used as drug delivery systems (DDS) and for biomedical imaging. Therapeutic and diagnostic agents can be incorporated into the silica matrix to improve the stability and dissolution of drug substances in biological systems. However, the safety of SNPs as drug carriers remains controversial. To date, no validated and accepted nano-specific tests exist to predict the potentially harmful impact of these materials on the human body.
Original language | Undefined/Unknown |
---|---|
Pages (from-to) | 355–363 |
Journal | Toxicology in Vitro |
Volume | 30 |
Issue number | 1 |
DOIs | |
Publication status | Published - 2015 |
MoE publication type | A1 Journal article-refereed |